Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TrueLok Elevate PMCF Study

NCT: NCT07079774 · RECRUITING

NCT IDNCT07079774
StatusRECRUITING
Start Date2025-11-24
Completion2028-11-24

Brief Summary

The TrueLok Elevate Transverse Bone Transport System is a modular external fixation device designed for transverse bone transport. It promotes local vascular and wound healing through controlled corticotomy and gradual distraction. The system is intended for adult patients with bony and/or soft tissuedefects.

Frequently Asked Questions

What is TrueLok Elevate PMCF Study?

TrueLok Elevate PMCF Study is a clinical trial registered under NCT07079774. Current status: RECRUITING.

What is the status of NCT07079774?

The current status of NCT07079774 (TrueLok Elevate PMCF Study) is: RECRUITING.

When did TrueLok Elevate PMCF Study start?

TrueLok Elevate PMCF Study started on 2025-11-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑